Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Recruiting1
Other3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04897022Phase 1Active Not Recruiting
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
Malignant Pleural Mesothelioma
PrincipalinvestigatorStart date: 2021-08-10
NCT04716946Phase 2Active Not Recruiting
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
Lung CancerNon-small Cell Lung CancerNon-small Cell Lung Cancer Stage I+5 more
PrincipalinvestigatorStart date: 2021-01-27

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David S Schrump, M.D.

National Cancer Institute (NCI)

Related
21 trials

Shared therapeutic areas:

MesotheliomaCarcinoma, Non-Small-Cell LungLung Cancer+1 more
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung CancerMesothelioma
Similarity Score8%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung CancerNSCLC

Worked with same sponsors:

AstraZeneca
Similarity Score8%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell LungMesothelioma
Similarity Score8%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Lung CancerMesotheliomaCarcinoma, Non-Small-Cell Lung
Similarity Score8%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Lung CancerNSCLC
Similarity Score5%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell Lung
Similarity Score5%

Yongchang Zhang, MD

Hunan Cancer Hospital

Related
27 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Cancer
Similarity Score5%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell Lung
Similarity Score5%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungNSCLC
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05354570Phase 2PrincipalInvestigator

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest

Pleural MetastasesThymic Malignancies
Recruiting
NCT04897022Phase 1PrincipalInvestigator

A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

Malignant Pleural Mesothelioma
Active Not Recruiting
NCT04716946Phase 2PrincipalInvestigator

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Lung CancerNon-small Cell Lung CancerNon-small Cell Lung Cancer Stage I+5 more
Active Not Recruiting
NCT00715611Phase 2PrincipalInvestigator

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Mesothelioma
Active Not Recruiting

All 4 trials loaded